Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
19.10
-0.70 (-3.54%)
At close: Feb 26, 2026
-28.73%
Market Cap 46.92M
Revenue (ttm) 114.04M
Net Income (ttm) 4.62M
Shares Out 2.46M
EPS (ttm) 1.88
PE Ratio 10.15
Forward PE n/a
Dividend 0.50 (2.62%)
Ex-Dividend Date Sep 11, 2025
Volume 79
Average Volume 199
Open 19.50
Previous Close 19.80
Day's Range 19.00 - 19.50
52-Week Range 17.30 - 32.00
Beta 0.20
RSI 33.15
Earnings Date Feb 13, 2026

About Biogened

Biogened S.A. produces and sells cosmetics and toiletries in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 195
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2025, Biogened's revenue was 114.04 million, an increase of 2.81% compared to the previous year's 110.93 million. Earnings were 4.62 million, a decrease of -20.59%.

Financial Statements

News

There is no news available yet.